DJIA 16,722.06 260.74 1.58%
NASDAQ 4,464.34 81.49 1.86%
S&P 500 1,956.69 29.58 1.53%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Sarepta Therapeutics' (SRPT) CEO Chris Garabedian at Morgan Stanley Healthcare Conference (Transcrip

Sarepta Therapeutics' (SRPT) CEO Chris Garabedian at Morgan Stanley Healthcare Conference (Transcript)

Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity

Ebola Outbreak Strikes Africa: How We're Fighting Back

Multiple drugs and vaccines are in development.

4 Companies To Look At After WHO Ebola Consultation In Geneva

The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks

Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog

Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog

Biotechs That Might Benefit From Ebola

Today's Market: News Moving These Names

Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT)

Sarepta's (SRPT) CEO Chris Garabedian on Q2 2014 Results - Earnings Call Transcript

See More Articles...